Burden of liver complications related to non-alcoholic fatty liver disease in China from 2005 to 2019: Observations from the Global Burden of Disease Study, 2019

被引:12
作者
Liu, Huixin [1 ]
Qi, Jinlei [2 ]
Yang, Jia [3 ]
Liu, Feng [3 ]
Li, Xiaohe [3 ]
Yin, Peng [2 ]
Wang, Lijun [2 ]
Liang, Zhisheng [4 ]
Wei, Lai [5 ]
Rao, Huiying [3 ,6 ]
Zhou, Maigeng [2 ,7 ]
机构
[1] Peking Univ Peoples Hosp, Dept Clin Epidemiol & Biostat, Beijing, Peoples R China
[2] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pre, Beijing, Peoples R China
[3] Peking Univ Peoples Hosp, Peking Univ Hepatol Inst, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing Int Cooperat Base Sci & Technol NAFLD Diag, Beijing, Peoples R China
[4] Peking Univ, Sch Publ Hlth, Dept Global Hlth, Beijing, Peoples R China
[5] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Hepatopancreato Biliary Ctr, Sch Clin Med, Beijing, Peoples R China
[6] Peking Univ Peoples Hosp, Peking Univ Hepatol Inst, Peking Univ Hlth Sci Ctr, Beijing 100044, Peoples R China
[7] Natl Ctr Chron & Noncommunicable Dis Control & Pre, Beijing 100050, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
fatty liver disease; liver; observational study; population study; PREVALENCE; SMOKING; RISK;
D O I
10.1111/dom.15010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To assess the burden of liver complications related to non-alcoholic fatty liver disease (LC-NAFLD) from 2005 to 2019 in China.Materials and Methods: We used data from the Global Burden of Disease, Injuries, and Risk Factors Study, 2019, to present contemporary and varying profiles of China's LC-NAFLD burden. The Joinpoint Regression model and Gaussian process regression were, respectively, used to estimate the annual percentage change in prevalence rates and disability-adjusted life-year (DALY) rates, and the relationship between the socio-demographic index (SDI) and age-standardized rates of LC-NAFLD.Results: In 2019, China had 293.42 million (95% uncertainty interval [UI]: 263.69-328.44) LC-NAFLD cases with a prevalence rate and DALYs of 20.63 (95% UI: 23.09-18.54) per 1000 people and 591.03 thousand (95% UI: 451.25-737.33), respectively. North China had the highest prevalence but the lowest DALYs of LC-NAFLD, whereas Southwest China had the lowest prevalence but the highest DALYs. LC-NAFLD were more common in men than in women (male: female ratio, 1.27) in 2019. From 2005 to 2019, the prevalence of NAFLD cases increased by 68.32% (from 174.32 million in 2005 to 293.42 million in 2019), mainly because of an age-specific prevalence rate increase.Conclusion: The LC-NAFLD burden in China is substantial and has increased markedly over the past 15 years. Effective measures for low SDI regions and men are needed to address the rapidly increasing NAFLD burden.
引用
收藏
页码:43 / 52
页数:10
相关论文
共 36 条
[1]  
Abbafati C, 2020, LANCET, V396, P1204
[2]   The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015 [J].
Akinyemiju, Tomi ;
Abera, Semaw ;
Ahmed, Muktar ;
Alam, Noore ;
Alemayohu, Mulubirhan Assefa ;
Allen, Christine ;
Al-Raddadi, Rajaa ;
Alvis-Guzman, Nelson ;
Amoako, Yaw ;
Artaman, Al ;
Ayele, Tadesse Awoke ;
Barac, Aleksandra ;
Bensenor, Isabela ;
Berhane, Adugnaw ;
Bhutta, Zulfiqar ;
Castillo-Rivas, Jacqueline ;
Chitheer, Abdulaal ;
Choi, Jee-Young ;
Cowie, Benjamin ;
Dandona, Lalit ;
Dandona, Rakhi ;
Dey, Subhojit ;
Dicker, Daniel ;
Phuc, Huyen ;
Ekwueme, Donatus U. ;
Zaki, Maysaa El Sayed ;
Fischer, Florian ;
Furst, Thomas ;
Hancock, Jamie ;
Hay, Simon I. ;
Hotez, Peter ;
Jee, Sun Ha ;
Kasaeian, Amir ;
Khader, Yousef ;
Khang, Young-Ho ;
Kumar, G. Anil ;
Kutz, Michael ;
Larson, Heidi ;
Lopez, Alan ;
Lunevicius, Raimundas ;
Malekzadeh, Reza ;
McAlinden, Colm ;
Meier, Toni ;
Mendoza, Walter ;
Mokdad, Ali ;
Moradi-Lakeh, Maziar ;
Nagel, Gabriele ;
Nguyen, Quyen ;
Nguyen, Grant ;
Ogbo, Felix .
JAMA ONCOLOGY, 2017, 3 (12) :1683-1691
[3]   Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: Focusing on the non-overlap groups [J].
Ayada, Ibrahim ;
van Kleef, Laurens A. ;
Alferink, Louise J. M. ;
Li, Pengfei ;
de Knegt, Robert J. ;
Pan, Qiuwei .
LIVER INTERNATIONAL, 2022, 42 (02) :277-287
[4]   Gut bacteria alleviate smoking-related NASH by degrading gut nicotine [J].
Chen, Bo ;
Sun, Lulu ;
Zeng, Guangyi ;
Shen, Zhe ;
Wang, Kai ;
Yin, Limin ;
Xu, Feng ;
Wang, Pengcheng ;
Ding, Yong ;
Nie, Qixing ;
Wu, Qing ;
Zhang, Zhiwei ;
Xia, Jialin ;
Lin, Jun ;
Luo, Yuhong ;
Cai, Jie ;
Krausz, Kristopher W. ;
Zheng, Ruimao ;
Xue, Yanxue ;
Zheng, Ming-Hua ;
Li, Yang ;
Yu, Chaohui ;
Gonzalez, Frank J. ;
Jiang, Changtao .
NATURE, 2022, 610 (7932) :562-+
[5]  
Chen H., 2022, NEOPLASIA, V8
[6]   Estimating average annual per cent change in trend analysis [J].
Clegg, Limin X. ;
Hankey, Benjamin F. ;
Tiwari, Ram ;
Feuer, Eric J. ;
Edwards, Brenda K. .
STATISTICS IN MEDICINE, 2009, 28 (29) :3670-3682
[7]   Higher Healthy Lifestyle Score is associated with lower presence of non-alcoholic fatty liver disease in middle-aged and older Chinese adults: a community-based cross-sectional study [J].
Deng, Yun-yang ;
Zhong, Qing-wei ;
Zhong, Hai-li ;
Xiong, Feng ;
Ke, Yue-bin ;
Chen, Yu-ming .
PUBLIC HEALTH NUTRITION, 2021, 24 (15) :5081-5089
[8]   Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease [J].
Estes, Chris ;
Razavi, Homie ;
Loomba, Rohit ;
Younossi, Zobair ;
Sanyal, Arun J. .
HEPATOLOGY, 2018, 67 (01) :123-133
[9]  
Ge Xiaojun, 2020, BMJ Open, V10, pe036663, DOI 10.1136/bmjopen-2019-036663
[10]   Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019 [J].
Golabi, Pegah ;
Paik, James M. ;
AlQahtani, Saleh ;
Younossi, Youssef ;
Tuncer, Gabriela ;
Younossi, Zobair M. .
JOURNAL OF HEPATOLOGY, 2021, 75 (04) :795-809